These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 32616439)

  • 21. Complex Pathologic Roles of RIPK1 and RIPK3: Moving Beyond Necroptosis.
    Wegner KW; Saleh D; Degterev A
    Trends Pharmacol Sci; 2017 Mar; 38(3):202-225. PubMed ID: 28126382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Necroptosis in development and diseases.
    Shan B; Pan H; Najafov A; Yuan J
    Genes Dev; 2018 Mar; 32(5-6):327-340. PubMed ID: 29593066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NFκB and ubiquitination: partners in disarming RIPK1-mediated cell death.
    O'Donnell MA; Ting AT
    Immunol Res; 2012 Dec; 54(1-3):214-26. PubMed ID: 22477525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis.
    Orozco S; Yatim N; Werner MR; Tran H; Gunja SY; Tait SW; Albert ML; Green DR; Oberst A
    Cell Death Differ; 2014 Oct; 21(10):1511-21. PubMed ID: 24902904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Holding RIPK1 on the Ubiquitin Leash in TNFR1 Signaling.
    Peltzer N; Darding M; Walczak H
    Trends Cell Biol; 2016 Jun; 26(6):445-461. PubMed ID: 26877205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3.
    Dillon CP; Weinlich R; Rodriguez DA; Cripps JG; Quarato G; Gurung P; Verbist KC; Brewer TL; Llambi F; Gong YN; Janke LJ; Kelliher MA; Kanneganti TD; Green DR
    Cell; 2014 May; 157(5):1189-202. PubMed ID: 24813850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The latest information on the RIPK1 post-translational modifications and functions.
    Wang Q; Fan D; Xia Y; Ye Q; Xi X; Zhang G; Xiao C
    Biomed Pharmacother; 2021 Oct; 142():112082. PubMed ID: 34449307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RIPK3 contributes to TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions of cIAP1/2 depletion or TAK1 kinase inhibition.
    Dondelinger Y; Aguileta MA; Goossens V; Dubuisson C; Grootjans S; Dejardin E; Vandenabeele P; Bertrand MJ
    Cell Death Differ; 2013 Oct; 20(10):1381-92. PubMed ID: 23892367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury.
    Newton K; Dugger DL; Maltzman A; Greve JM; Hedehus M; Martin-McNulty B; Carano RA; Cao TC; van Bruggen N; Bernstein L; Lee WP; Wu X; DeVoss J; Zhang J; Jeet S; Peng I; McKenzie BS; Roose-Girma M; Caplazi P; Diehl L; Webster JD; Vucic D
    Cell Death Differ; 2016 Sep; 23(9):1565-76. PubMed ID: 27177019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-intrinsic and immune modulatory roles of receptor-interacting protein kinases.
    Rucker AJ; Chan FK
    Trends Biochem Sci; 2022 Apr; 47(4):342-351. PubMed ID: 34998669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FKBP12 mediates necroptosis by initiating RIPK1-RIPK3-MLKL signal transduction in response to TNF receptor 1 ligation.
    Wang Z; Feng J; Yu J; Chen G
    J Cell Sci; 2019 May; 132(10):. PubMed ID: 31028177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential roles of RIPK1 and RIPK3 in TNF-induced necroptosis and chemotherapeutic agent-induced cell death.
    Moriwaki K; Bertin J; Gough PJ; Orlowski GM; Chan FK
    Cell Death Dis; 2015 Feb; 6(2):e1636. PubMed ID: 25675296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diverse ubiquitin linkages regulate RIP kinases-mediated inflammatory and cell death signaling.
    Witt A; Vucic D
    Cell Death Differ; 2017 Jul; 24(7):1160-1171. PubMed ID: 28475174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RIPK1 inhibits ZBP1-driven necroptosis during development.
    Newton K; Wickliffe KE; Maltzman A; Dugger DL; Strasser A; Pham VC; Lill JR; Roose-Girma M; Warming S; Solon M; Ngu H; Webster JD; Dixit VM
    Nature; 2016 Dec; 540(7631):129-133. PubMed ID: 27819682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RIPK1-RIPK3-MLKL-Associated Necroptosis Drives
    Barbosa LA; Fiuza PP; Borges LJ; Rolim FA; Andrade MB; Luz NF; Quintela-Carvalho G; Lima JB; Almeida RP; Chan FK; Bozza MT; Borges VM; Prates DB
    Front Immunol; 2018; 9():1818. PubMed ID: 30154785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RIPK3 in cell death and inflammation: the good, the bad, and the ugly.
    Orozco S; Oberst A
    Immunol Rev; 2017 May; 277(1):102-112. PubMed ID: 28462521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Receptor Interacting Protein Kinases in the Liver.
    Dara L
    Semin Liver Dis; 2018 Feb; 38(1):73-86. PubMed ID: 29471568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RIPK1/RIPK3 promotes vascular permeability to allow tumor cell extravasation independent of its necroptotic function.
    Hänggi K; Vasilikos L; Valls AF; Yerbes R; Knop J; Spilgies LM; Rieck K; Misra T; Bertin J; Gough PJ; Schmidt T; de Almodòvar CR; Wong WW
    Cell Death Dis; 2017 Feb; 8(2):e2588. PubMed ID: 28151480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Triad3a induces the degradation of early necrosome to limit RipK1-dependent cytokine production and necroptosis.
    Alturki NA; McComb S; Ariana A; Rijal D; Korneluk RG; Sun SC; Alnemri E; Sad S
    Cell Death Dis; 2018 May; 9(6):592. PubMed ID: 29789521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The death-inducing activity of RIPK1 is regulated by the pH environment.
    Moriwaki K; Balaji S; Ka-Ming Chan F
    Sci Signal; 2020 May; 13(631):. PubMed ID: 32398349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.